Literature DB >> 29320796

Prevalence and Risk Factors of Acute Pulmonary Embolism in Patients with Lung Cancer Surgery.

Yu-Ping Li1, Lei Shen1, Wei Huang1, Xue-Fei Hu1, Dong Xie1, Jian Yang1, Xiao Song1, Yan-Feng Zhao1, Chao-Jie Zhou1, Ge-Ning Jiang1.   

Abstract

Acute pulmonary embolism (PE) is one of the serious complications with high mortality after thoracic surgery. The authors aimed to determine the prevalence of PE events and evaluate additional risk factors for PE in patients with lung cancer surgery. Patients underwent lung cancer resections during January 2012 to July 2015 and had 30-day postoperative follow-up were included. Those with incomplete or miscoded data were excluded. The number of postoperative PE events was recorded retrospectively. Analyses were used to evaluate risk factors of PE during the hospitalization. The authors reviewed 11,474 patients who underwent surgery for lung cancer. The overall 30-day incidence of PE after thoracic surgery at their institution was 0.53%. The 30-day PE incidence without chemical prophylaxis was 0.57% (55/9,726) and the mortality rate was 10%. Multivariate analyses revealed that age over 66 (odds ratio [OR]: 1.09, 95% confidence interval [CI]: 1.05-1.12, p < 0.001), more extensive surgery than lobectomy (OR: 2.34, 95% CI: 1.28-4.25, p = 0.006) and stage IV of lung cancer (OR: 4.22, 95% CI: 1.50-11.9, p = 0.007) were associated with an increased risk of PE. Using these additional risk factors, based on readily available clinical characteristics, can help to risk-stratify patients and warrant extended chemical prophylaxis for patients to reduce the incidence of acute PE. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 29320796     DOI: 10.1055/s-0037-1612625

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

1.  Prognostic role of the preoperative neutrophil-to-lymphocyte ratio and albumin for 30-day mortality in patients with postoperative acute pulmonary embolism.

Authors:  Chuan Liu; Hui-Lu Zhan; Zhang-Heng Huang; Chuan Hu; Yue-Xin Tong; Zhi-Yi Fan; Meng-Ying Zheng; Cheng-Liang Zhao; Gui-Yun Ma
Journal:  BMC Pulm Med       Date:  2020-06-24       Impact factor: 3.317

2.  Derivation and validation of a nomogram model for pulmonary thromboembolism in patients undergoing lung cancer surgery.

Authors:  Yuping Li; Lei Shen; Junrong Ding; Dong Xie; Jian Yang; Yanfeng Zhao; Angelo Carretta; René Horsleben Petersen; Sebastien Gilbert; Yasuhiro Hida; Servet Bölükbas; Hiran C Fernando; Gening Jiang; Yuming Zhu
Journal:  Transl Lung Cancer Res       Date:  2021-04

3.  Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis.

Authors:  Liu Junjun; Wang Pei; Yan Ying; Song Kui
Journal:  Sci Rep       Date:  2020-01-27       Impact factor: 4.379

4.  [Clinical Value Evaluation of Perioperative Prophylactic Anticoagulation Therapy for Lung Cancer Patients].

Authors:  Hui Xu; Hu Liao; Guowei Che; Kun Zhou; Mei Yang; Lunxu Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-10-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.